期刊文献+

冠脉介入治疗对老年糖尿病患者血清胱抑素C和肾功能的影响 被引量:8

下载PDF
导出
摘要 目的观察老年糖尿病患者行冠状动脉介入治疗后肾功能的变化,探讨血胱抑素C(Cys-C)对老年糖尿病患者造影剂肾病的诊断价值。方法选取行冠状动脉介入检查及治疗的老年糖尿病患者40例,分别在术前、术后1、2、3d采用苦味酸法测血肌酐,采用颗粒增强透射免疫比浊法测血清Cys-C,并计算内生肌酐清除率(Ccr),观察造影剂对患者肾功能损害的情况。结果老年糖尿病患者造影剂肾病的发生率为18%,Cys-C在术后1、2天明显升高,与术前比较差异有统计学意义(P<0.01);Ccr在术后1、2d明显下降,与术前比较差异有统计学意义(P<0.01),Scr术后2d轻微升高,与术前比较差异有统计学意义(P<0.05)。结论对于肾功能正常的老年糖尿病患者仍是造影剂肾病的高危因素,应用血肌酐评价可能低估造影剂肾损害,应该更多关注内生Ccr,而血清Cys-C能很好的反映内生肌酐清除率的水平。
出处 《河北医药》 CAS 2012年第3期352-353,共2页 Hebei Medical Journal
  • 相关文献

参考文献4

二级参考文献23

  • 1曹滢,郭晖.冠心病介入治疗的围手术期护理[J].局解手术学杂志,2004,13(4):242-242. 被引量:21
  • 2韩雅玲,臧红云,荆全民,王守力,王冬梅,王祖禄.冠心病合并慢性肾功能不全介入诊断或治疗围术期的肾功能保护[J].中国危重病急救医学,2004,16(9):530-532. 被引量:14
  • 3孙蔚明,杜晔.非离子型造影剂致肾损害的临床分析[J].中国医学影像学杂志,2005,13(4):284-287. 被引量:24
  • 4Sousa CS, Pedro MM, Pinto FJ. Contrast-induced nephropathy following percutaneous coronary intervention: case report[J]. Rev PortCardiol, 2009, 28 (3) : 309-321.
  • 5Murghy SW, Barrett BJ, Pafrey PS.Contrast nephropathy[J]. J Am Soc Nephrol, 2000, 11 (2) : 177-182.
  • 6Gruberg L, Mehran R, Dangas G, et al.Acute renal failure requiring dialysis after percutaneous coronary interventions[J]. Cathet Cardiovasc Interven, 2001, 52: 409--416.
  • 7Richard J Solomon, Madhu K Natarajan, Serge Doucet, et al. Cardiac angiography in renally impaired patients (CARE) study,A randomized double-blind trial of contrast- induced nphropathy in ptients with chronic kidney disease[J].Circulation, 2007, 115: 3189-3196.
  • 8Pdhal CS, Texter SC, Gill DE, et al.Incidence and prognostic importance of acute renal failure after perentaneour coronary imervention[J].Circulation, 2002, 105(19): 2259-2262.
  • 9Richard JS, Madhu KN, Serge D, et al.Sodium bicarbonate vs sodium chloride for the prevention of contrast medium- induced nephropathy in patients undergoing coronary angiography: A randomized trial[J].JAMA, 2008, 300:1038-1046.
  • 10Peter A, Nephrotoxicity and the role of contrast media [J]. Radiat Meal,2004,22:377-401.

共引文献8

同被引文献61

  • 1戴金英,黎观妹.冠心病合并糖尿病患者行冠脉介入性治疗的护理[J].现代护理,2005,11(16):1320-1321. 被引量:7
  • 2Nash K,Hafeez A,Hou S. Hospital-acquired renal in sufficiency[ J].Am J Kidney Disease,2002,39(5) :930-936.
  • 3Malhis M,Al-Bitar S,Al-Deen Zaiat K. The role of theophylline in pre-vention of radiocontrast media-induced nephropathy [ J]. Saudi J Kid-ney Dis Transpl,2010,21 (2) :276-283.
  • 4Filler G,Bokenkamp A,Hofmann W,et al. Cystatin C as a marker ofGFR-history,indications,and future research [ J ]. Clin BiocKem,2005,38(1) :l-8.
  • 5Bachorzewska-Gajewska H,Malyszko J,Sitniewska E,et al. Could neu-trophil-gelatinase-associated lipocalin and Cystatin C predict the devel-opment of contrast-induced nephropathy after percutaneous coronaryinterventions in patients with stable angina and normal serum creatinievalues. [ J]. Kidney Blood Press Res,2007,30(6) :408-415.
  • 6Herget-Rosenthal S,Marggraf G,Husing J,et al. Early detection of a-cute renal failure by serum cystatin C [ J ] . Kidney Int,2004,66 (3 ):1115-1122.
  • 7Rickli H,Benou K,Ammann P,et al. Time course of serial cystatin Clevels in comparison with serum creatinine after application of Radiocontrast media[j]. Clin Nephrol,2004,61 (2) :98-102.
  • 8Kimmel M,Butscheid M,Brenner S,et al. Improved estimation of glo-merular filtration rate by serum cystatin C in preventing contrast in-duced nephropathy by N-acetylcysteine or zinc-preliminary results[ J].Nephrol Dial Transplant,2008 ,23 (4) :1241-1245.
  • 9梁焕兰,朱娟.急性冠脉综合症合并糖尿病患者冠脉介入治疗术后的护理[J].医药与保健,2009,17(6):7-9.
  • 10Yoon H J, Kim H, Lee JP, et al. The efficacy of the cysta- tin C based glomerular filtration rate in the estimation of safe contrast media volume[J]. Korean Circ J, 2013,43 (9) :622-627.

引证文献8

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部